Product Information
DROXIDOPA 200 MG CAPSULE is a generic product labeled by Slate Run Pharmaceuticals LLC, priced at $1.2814 per EA under NDC 70436014106. Its NADAC has been published 84 times since Aug 16, 2023.
Strength
200 mg/1
Manufacturer
Slate Run Pharmaceuticals LLCNDC
70436014106
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
4/23/2025
Active Ingredients
DROXIDOPAApproval Type
Generic (ANDA)
FDA Application
ANDA215265On Market Since
11/10/2021
Pharmacological Classes
Price Statistics
The NADAC for DROXIDOPA 200 MG CAPSULE has been published 84 times since Aug 16, 2023, and over the history we have for it it has declined 39.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.2814 per EA |
|---|---|
| All-time high | $2.3453 (Jul 10, 2024) |
| All-time low | $1.2814 (Apr 23, 2025) |
| Median price | $1.9388 |
| Average price | $1.8834 |
| Largest weekly change | -25.1% (Jul 17, 2024) |
| Weeks tracked | 84 |
| Tracking since | Aug 16, 2023 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 12% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of DROXIDOPA 200 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for DROXIDOPA 200 MG CAPSULE, manufactured by Slate Run Pharmaceuticals LLC, is $1.2814 per EA (NDC 70436014106), effective May 14, 2025.
How has the price of DROXIDOPA 200 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for DROXIDOPA 200 MG CAPSULE has declined 39.8%. It has been tracked across 84 weekly CMS publications since Aug 16, 2023.
What are the highest and lowest recorded NADAC prices for DROXIDOPA 200 MG CAPSULE?
Since Aug 16, 2023, the NADAC for DROXIDOPA 200 MG CAPSULE has ranged from a low of $1.2814 (Apr 23, 2025) to a high of $2.3453 (Jul 10, 2024), with a median of $1.9388 per EA.
Are there cheaper alternatives to DROXIDOPA 200 MG CAPSULE?
Yes. 2 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, DROXIDOPA 200 MG CAPSULE, is $1.1305 per EA — about 12% below DROXIDOPA 200 MG CAPSULE.
Who manufactures DROXIDOPA 200 MG CAPSULE?
DROXIDOPA 200 MG CAPSULE (NDC 70436014106) is labeled by Slate Run Pharmaceuticals LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification